Autres langues Quest Diagnostics Incorporated

Actions

DGX

US74834L1008

Installations et services en soins de santé

Temps réel estimé Cboe BZX 19:03:43 05/10/2026			Varia. 5j.	Varia. 1 janv.
232,27 ^USD	-0,45%		-2,34%	+33,73%

01/10	Quest Diagnostics publie les performances cliniques du test Haystack MRD dans une cohorte d’échantillons issue des essais DYNAMIC sur le cancer colorectal	CI
22/09	Quest Diagnostics et Labcorp reculent après l’annonce par Medicare de baisses des taux de remboursement des analyses de laboratoire	MT

Autres langues

01/10	Quest Diagnostics Reports Haystack MRD Test Clinical Performance In Specimen Cohort From DYNAMIC Colorectal Cancer Trials
01/10	Haystack MRD® Demonstrates Robust Clinical Performance in Specimen Cohort from the Landmark DYNAMIC Colorectal Cancer Trials
22/09	Quest Diagnostics to Release Third Quarter Financial Results on October 22, 2026
22/09	Diagnostic-Testing Stocks Slide After Proposed Cuts to Medicare Payments for Lab Services
22/09	Quest Diagnostics, Labcorp Shares Fall as Medicare Signals Cuts in Payment Rates for Lab Services
21/09	Nearly 1 in 3 Patients with Suspected Lyme Disease are Co-Positive for Other Tick-Borne Pathogens, Finds Study by Quest Diagnostics
16/09	Nine in 10 Voters Express Concern That Medicare Lab Payment Cuts Will Harm Patient Access to Diagnostic Lab Testing, Finds National Survey from Quest Diagnostics
09/09	Quest Diagnostics Announces Apple Health App Users to Be Able to Order Labs from Quest Diagnostics
09/09	Apple Health app Users to be Able to Order Labs from Quest Diagnostics
03/09	Quest Diagnostics Insider Sold Shares Worth $2,427,200, According to a Recent SEC Filing
01/09	Renalytix plc and Quest Diagnostics Enter Agreement to Expand Kidneyintelx.Dkd Testing in the United States
31/08	GoodLife Health Bundles Quarterly ApoB Testing Into $299 Membership
25/08	Humanity Health Inc. And Quest Diagnostics Announce Availability Of Humanity Biological Age Analysis Through questhealth.com
25/08	Quest Diagnostics to Speak at the Baird 2026 Global Healthcare Conference
25/08	Humanity Brings Biological Age Analysis to the U.S. Through questhealth.com
24/08	Quest Diagnostics to Add Roche's Elecsys to Alzheimer's Biomarker Test Portfolio
24/08	Quest Diagnostics to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference
24/08	Quest Diagnostics Announces Addition of FDA-Cleared Elecsys Ptau217 Test and Launches New Multi-Biomarker Ad-Detect Blood Test
24/08	FDA Approves Alzheimer's Blood Test Developed by Roche and Eli Lilly
24/08	Roche, Eli Lilly's Alzheimer's blood test gets FDA clearance
24/08	Quest Diagnostics to Offer FDA-Cleared Roche pTau217 Blood Test to Assess Alzheimer's Disease Pathology
12/08	Quest Diagnostics Keeps Quarterly Dividend at $0.86 per Share, Payable Oct. 21, to Shareholders of Record Oct. 6
12/08	Quest Diagnostics Declares Quarterly Cash Dividend
12/08	Quest Diagnostics Incorporated Declares Quarterly Cash Dividend, Payable on October 21, 2026
30/07	Labcorp raises annual profit forecast on strong testing demand